Yifeng Xia
Impact in
- Cancer Research top 2%
- NF-κB Signaling Pathways
- Cancer-related molecular mechanisms research
- Immunology top 5%
- interferon and immune responses
- Immune Response and Inflammation
Papers in
-
- RNA Interference and Gene Delivery 7
- Oncology 10
- Lung Cancer Research Studies 3
- Co-authors
- Inder M. Verma (11 shared papers)Shen Shen (2 shared papers)Fenghua Meng (18 shared papers)Zhiyuan Zhong (18 shared papers)Fei Liu (2 shared papers)Yan Zou (5 shared papers)Narayana Yeddula (5 shared papers)Eugene Ke (4 shared papers)
- Journals
- Bioactive Materials (2 papers)Proceedings of the National Academy of Sciences (2 papers)Journal of Controlled Release (2 papers)Molecular Pharmaceutics (2 papers)Biomacromolecules (2 papers)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Yifeng Xia
43 papers receiving 2.4k citations
Yifeng Xia's Hit Papers
Peers
Comparison fields: 5 of 123
- Cancer Research 625
- Immunology 513
- Biomaterials 286
- Oncology 515
- Molecular Biology 1.2k
Countries citing papers authored by Yifeng Xia
This map shows the geographic impact of Yifeng Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yifeng Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yifeng Xia more than expected).
Fields of papers citing papers by Yifeng Xia
This network shows the impact of papers produced by Yifeng Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yifeng Xia. The network helps show where Yifeng Xia may publish in the future.
Co-authors
The 25 scholars most cited alongside Yifeng Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | NF-κB, an Active Player in Human Cancers Hit paper breakdown → | 2014 | 960 |
| 2 | 2012 | 204 | |
| 3 | 2009 | 125 | |
| 4 | 2012 | 112 | |
| 5 | 2016 | 112 | |
| 6 | 2022 | 70 | |
| 7 | 2021 | 63 | |
| 8 | 2018 | 60 | |
| 9 | 2022 | 56 | |
| 10 | 2017 | 46 | |
| 11 | 2014 | 45 | |
| 12 | 2016 | 44 | |
| 13 | 2024 | 43 | |
| 14 | 2018 | 43 | |
| 15 | 2017 | 42 | |
| 16 | 2018 | 37 | |
| 17 | 2021 | 37 | |
| 18 | 2015 | 33 | |
| 19 | 2020 | 32 | |
| 20 | 2010 | 30 |
About Yifeng Xia
Yifeng Xia is a scholar working on Molecular Biology, Oncology, Biomaterials, Immunology and Biomedical Engineering, having authored 44 papers that have together received 2.5k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (10 papers), Nanoplatforms for cancer theranostics (8 papers), RNA Interference and Gene Delivery (7 papers), NF-κB Signaling Pathways (6 papers), Advancements in Battery Materials (5 papers), interferon and immune responses (4 papers), Cancer Research and Treatments (4 papers) and Lung Cancer Research Studies (3 papers). The work is most often cited by research in Cancer Research (625 citations), Immunology (513 citations), Biomaterials (286 citations), Oncology (515 citations) and Molecular Biology (1.2k citations). Yifeng Xia has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Inder M. Verma, Shen Shen, Fenghua Meng, Zhiyuan Zhong, Fei Liu, Yan Zou, Narayana Yeddula, Eugene Ke, Beibei Guo and Weijing Yang. Their work appears in journals such as Bioactive Materials, Proceedings of the National Academy of Sciences, Journal of Controlled Release, Molecular Pharmaceutics and Biomacromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.